Pharmaceuticals, Biotechnology and Life Sciences
Series C financing supports continued clinical development of the Acolyte™ Image-Guided coronary chronic total occlusion (CTO) platform, an FDA Breakthrough…
ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for…
Collaboration expands patient access to the Company’s prescription treatments through online telehealth consultations PARSIPPANY, N.J.–(BUSINESS WIRE)–YARAL Pharma Inc. (YARAL Pharma),…
Strategic data collaborations expand Within3’s Launch Intelligence™ platform while maintaining governed, privacy-compliant standards CLEVELAND–(BUSINESS WIRE)–#AI—Within3 today announced Dataverse, an ecosystem…
TOKYO–(BUSINESS WIRE)–Asahi Kasei Pharma, a global provider of healthcare and pharmaceutical solutions, in collaboration with Alchemedicine, has announced that its…
Yair Heller Appointed CEO and Co-Founder Joseph Mossel to Lead Strategic Growth Initiatives as Ibex Accelerates Global Impact BOSTON &…
MORRISTOWN, N.J.–(BUSINESS WIRE)–QPharma®, a leader in compliant HCP engagement and sampling solutions, launches a next‑generation digital sampling experience that integrates…
ATLANTA–(BUSINESS WIRE)–#Biotechnology–Axion BioSystems today announced that the FDA’s Center for Drug Evaluation and Research (CDER) has accepted the company’s letter…
TED-A9 is an allogeneic cell therapy in development for Parkinson’s disease Program builds on S.Biomedics’ growing pipeline of stem-cell-based therapies…
Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline across key clinical…